Connect with us

Press Release EU ZA

Ex-rugby international seeks £1 million Investment for CBD brand

Published

on


One of the UK’s fastest-growing wellness brands – which is backed by rugby stars including British and Irish Lion Finn Russell – has launched a crowdfunding campaign aiming to raise £1m to expand into retail and overseas markets.

Puresport was founded in Scotland by former international rugby player Grayson Hart in 2018, with online sales passing £3.5m this year.

It claims that more than 1,000 people have already pre-registered to join the investment round on crowdfunding platform Seedrs.

The firm began as a producer of CBD pain relief for athletes, and has since expanded into new markets including sleep, stress and fitness. Puresport turned over £2m before tax in 2021, with revenues on course to grow to £2.8m this year.

Earlier this year, it became one of the first CBD producers to gain approval for legal sale in the UK, following the introduction of new regulation by the Food Standards Agency (FSA).

Puresport was initially a side hustle for scrum-half Hart – who represented New Zealand U20s, Scotland in 7s and full internationals, and the Barbarians during his rugby career – but is now a full focus in retirement for the athlete who played for the Glasgow Warriors and Edinburgh Rugby.

The 33-year-old entrepreneur looked to natural products after realising the negative effects of relying on opioid-based painkillers to cope with the rigours of professional rugby.

The London-based start-up has attracted almost 50,000 followers across social media, with a model driven by collaborations with other fitness and wellness brands, including Gymshark.

The company has also circumvented restrictions on advertising CBD products online through its community of advocates, with more than 11,000 people attending the Puresport-run clubs, yoga classes, fitness summits and other brand events in the first half of 2022 alone.

Hart said: “We have built a business, but I’m more proud of the community we’ve created – our success has come from the bottom up.”

His former Scotland teammates Greig Laidlaw and Finn Russell are among those already committed to investing in this round, with more to be announced.

Scotland’s Greig Laidlaw and Finn Russell (Image: sns)

Puresport is also set to grow its team of 12. Its products were recently launched in more than 50 UK Flannels stores, with new e-commerce sites planned in Australia, New Zealand and the US.

Hart added: “We want everyone to benefit from our products, which means being in places like Selfridges and Harrods.

“We’re already experiencing sales from abroad and have had organic iterations of our run clubs in Dublin and Australia.

“We’ve seen how we’ve grown in the UK by starting a real movement, and we’ll do the same in new territories.

“We want to be the driving force behind a global shift towards natural products – mushrooms is an area that is particularly interesting to us and could hold the key to preventing illness and improving body and mind.”



Source link

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published.

Press Release EU ZA

High Tide Subsidiary Blessed CBD Launches Sales of Hemp-derived CBD Products on Amazon UK

Published

on

By


CALGARY, ABJuly 11, 2022 /PRNewswire/ – High Tide Inc. (“High Tide” or the “Company“) (Nasdaq: HITI) (TSXV: HITI) (FSE: 2LYA), a leading retail-focused cannabis company with bricks-and-mortar as well as global e-commerce assets, announced today that its subsidiary, Blessed CBD (“Blessed“), has begun sales of its premium hemp-derived CBD products on Amazon in the United Kingdom (“Amazon UK“). A range of Blessed CBD products, including gummies, capsules, and balms are now available on Amazon UK, and the remaining Blessed CBD products will be listed in the coming days. All Blessed products qualify for next-day delivery through Amazon Prime. Blessed also intends to list any future SKUs that it may add to its product lineup on the Amazon UK platform.

As with all other CBD retailers who are listed on Amazon UK, Blessed was invited by Amazon themselves to join the platform as a seller of CBD. Retailers that sell CBD through Amazon UK are required to have received Novel Foods Authorization from the United Kingdom’s Food Standards Agency as well as pass compliance checks conducted by Amazon.

“The listing of Blessed CBD products on Amazon UK represents a fantastic growth opportunity for Blessed and High Tide. Amazon is unmatched as a global online marketplace, and by joining their platform in the UK, we are broadening Blessed’s reach and making our products accessible for many more consumers,” said Raj Grover, President and Chief Executive Officer of High Tide. “Today’s announcement is another example of the strength of High Tide’s diversified international cannabis ecosystem, as we are able to keep growing our presence and customer bases even in jurisdictions where cannabis is not yet legal. As we further execute on our international strategy, we will continue to explore new and innovative distribution channels for our products, as well as additional markets where we can expand into through our existing and rapidly-expanding ancillary cannabis brand portfolio,” added Mr. Grover.

Primary Sponsor

New: Free USA Cannabis Case Law Search – New Cases Daily

Search Cannabis Law Report


Top Marijuana Blog



Source link

Continue Reading

Press Release EU ZA

Aurora Strengthens Leadership Position in Germany with EU-GMP Certification at Preeminent Local Cannabis Production Facility

Published

on

By


State-of-the-art facility readying first delivery of medical grade cannabis for German patients

EDMONTON, ABMay 18, 2022 /PRNewswire/ – Aurora Cannabis Inc. (the “Company” or “Aurora“) (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today the company has received EU-GMP certification for its state-of-the-art medical cannabis production facility in Germany. As a leading manufacturer of medical cannabis worldwide, achieving EU-GMP certification of the company’s first German manufacturing site marks a significant milestone in the fulfillment of an awarded tender by the German Federal Institute for Drugs and Medical Devices (BfArM). Aurora is the distinct market leader in the German flower segment and will now leverage receiving the world’s highest quality standard to produce and distribute premium medical cannabis in Germany.

The new state-of-the-art production facility in Leuna, Saxony-Anhalt, Germany adds to the company’s pan-European network of EU-GMP facilities supplying premium, high-quality cannabis flower and extracts for medical use by patients across existing and expanding markets. Germany’s medical cannabis market currently serves approximately 100,000 patients, representing only 0.1% of the population. In mature medical cannabis markets like Canada, market penetration is upwards of 1%, therefore the German market has significant potential for growth.

“With the EU-GMP certification of our first German site, we once again demonstrate Aurora’s excellence and leadership in establishing the necessary infrastructure to compete in the global cannabis market,” said Miguel Martin, CEO of Aurora Cannabis. “As a leading provider of medical cannabis in Germany and several other European markets, we are eager to accelerate patient access to high-quality, reliable cannabis produced in accordance with the most stringent criteria. Our first shipment from our world class Leuna facility will deliver on our commitment to the German regulatory authority and expanding patient base, a significant step in our ongoing commitment to international market growth.”

Aurora was awarded a tender/contract in 2019 by the German Federal Institute for Drugs and Medical Devices (BfArM) for the annual production of 1,000 kg of high-quality medical cannabis flower over a period of four years. Despite numerous challenges due to ongoing pandemic-related restrictions and international supply chain bottlenecks, the construction of Aurora Leuna, a nearly 3,600 sq. metre production site is complete, has received its EU-GMP certification and is preparing for the inaugural shipment. The first shipment from Aurora Leuna to German pharmacies is expected via the state’s cannabis agency later this month.

Martin continued “As a leading provider of cannabis flower and extracts in Germany, we are excited by the possibility of growth in the market. Our investment in domestic production with the highest quality standards will help advance patient access to high-quality cannabis. I congratulate our team in Germany on achieving this important milestone for our Leuna facility and the commencement of local production in this critical market.”

As a leading global cannabis company with a footprint on four continents, sales into 12 countries, and an expansive international production network, Aurora celebrates this important milestone in the company’s pursuit of enabling access to high-quality medical cannabis to patients worldwide.



Source link

Continue Reading

Press Release EU ZA

Greenrise Announces Appointment of Frank Otto to the Board of Directors and Closing of the Acquisition of Control of CannaCare Health GmbH

Published

on

By


HAMBURG, GermanyMay 11, 2022 /CNW/ – Greenrise Global Brands Inc. (Frankfurt: C4T) (ISIN: CA39540L1085) (CSE: XCX) (“Greenrise”), which serves the medical and CBD cannabis market in Germany and CannaCare Health GmbH (“CannaCare”), owner of CANOBO, one of Germany’s leading CBD brands announces the appointment of Mr. Frank Otto to the board of directors of Greenrise and the closing of the acquisition of 51% of CannaCare Health GmbH (“CannaCare”) previously announced on April 5th, 2022. Greenrise has the exclusive option to purchase 49% of CannaCare for two years after closing for common shares of Greenrise.

Mr. Otto is a German media entrepreneur and a pioneer in radio and television in Germany, and co-founder of CannaCare along with the Oplesch family. Mr. Otto founded VIVA Music Television together with Time Warner and Sony Television which was later acquired by MTV. Mr. Otto is the founder of Hamburg 1 television, one of Germany’s first private regional television stations. Mr. Otto is also the founder and owner of OK Radio, now renamed HAMBURG ZWEI, Delta Radio, 98.8 KISS FM Berlin and RauteMusik.FM, an internet radio station. Mr. Otto founded FerryHouse GmbH & Co KG, an independent music label in Germany and scored the soundtrack for Beautopia, which won the best documentary at the Chicago International Film Festival and was a nominee for the same category at the Sundance Film Festival. Mr. Otto was awarded the Order of Merit of the Federal Republic of Germany for special achievements in political, economic, cultural and intellectual fields.

Greenrise announces it has exchanged a €608,920 shareholder loan to CannaCare from Mr. Otto for a convertible debenture convertible into 4,201,552 Units where each Unit is comprised of one Greenrise common share (“Common Share”) and two share purchase warrants (“Warrant”), exercisable for one Common Share at an exercise price of C$0.35 at any time up to April 30th, 2023 and one Common Share at C$0.50 at any time up to April 30th, 2024. The convertible debenture is unsecured and due on December 31st, 2024, and bears interest at 2% per annum (“Otto Convertible Debenture”).

Mr. Otto currently owns 5% of Greenrise’s Common Shares and 18% of its Common Shares on a fully diluted basis.

Mr. Frank Otto, Director of Greenrise, commented, “My interest in cannabis began when I was young and noticed posters with the cannabis plant and the words ‘Legalize it’ at a concert by the rock band “The Who.” Today the legalization of adult use of cannabis in Germany will be a reality. I am a significant investor in Greenrise and CannaCare and fully support the development of the cannabis industry in Germany.”

Mr. Hendrik Knopp, Director of Greenrise, commented, “Mr. Otto is an established entrepreneur in Germany, and we are privileged to have him join our board of directors. Since the acquisition, we are seeing strong sales growth as CannaCare establishes CANOBO as the dominant CBD brand in Germany’s major drugstore chains.”

About CannaCare Health GmbH

CannaCare is one of the leading German wholesalers of high-quality cannabidiol (CBD) products in Hamburg, Germany. CannaCare has an extensive range of twenty CBD products consisting of tinctures, sprays and oils and skincare products made from natural raw materials and safe, clean, non-toxic products manufactured exclusively in Europe and Germany. CANOBO products meet all regulatory requirements in Germany and undergo a testing and release process to guarantee the best quality.

For more information about CannaCare, please visit www.cannacare-health.de



Source link

Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media